A1 Refereed original research article in a scientific journal

Polygenic Risk Scores for Predicting Adverse Outcomes After Coronary Revascularization




AuthorsAittokallio Jenni, Kauko Anni, Vaura Felix, Salomaa Veikko, Kiviniemi Tuomas; FinnGen, Schnabel Renate B, Niiranen Teemu

PublisherElsevier

Publication year2022

JournalAmerican Journal of Cardiology

Journal acronymAm J Cardiol

Volume167

First page 9

Last page14

DOIhttps://doi.org/10.1016/j.amjcard.2021.11.046

Web address 10.1016/j.amjcard.2021.11.046

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/68716440


Abstract

Coronary procedures predispose patients to adverse events. To improve our understanding of the genetic factors underlying postoperative prognosis, we studied the association of polygenic risk scores (PRSs) with postprocedural complications in coronary patients who underwent revascularization. The study sample comprised 8,296, 6,132, and 13,082 patients who underwent percutaneous coronary intervention, coronary artery bypass grafting, or any revascularization, respectively. We genotyped all subjects and identified adverse events during follow-up of up to 30 years by record linkage with nationwide healthcare registers. We computed PRSs for each postoperative adverse outcome (atrial fibrillation [AF], myocardial infarction, stroke, and bleeding complications) for all participants. Cox proportional hazards models were used to examine the association between PRSs and outcomes. A 1-SD increase in AF-PRS was associated with greater risk of postoperative AF with hazard ratios of 1.22 (95% confidence interval [CI] 1.16 to 1.28), 1.15 (95% CI 1.10 to 1.20) and 1.18 (95% CI 1.14 to 1.22) after percutaneous coronary intervention, coronary artery bypass grafting, and any revascularization, respectively. In contrast, the association of each PRSs with other postoperative complications was nonexistent to marginal. Inclusion of the AF-PRS in a model with a clinical risk score resulted in significant model improvement (increase in model c-statistic 0.0059 to 0.0098 depending on procedure; p <0.0002 for all). In conclusion, our results demonstrate that PRS can be used for AF risk-prediction in patients who underwent revascularization. The AF-PRS could potentially be used to improve AF prevention and outcomes in patients who underwent revascularization.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 13:27